Use of P53 silenced endothelial progenitor stem cells (hEPC) in diabetic peripheral vascular disease

Authors

Sabyasachi Sen MD, Baystate HealthFollow

Author Department

Medicine

Document Type

Presentations, Research

Publication Date

6-1-2011

Recommended Citation

Sen S, Young M, Jerry J. Use of P53 silenced endothelial progenitor stem cells (hEPC) in diabetic peripheral vascular disease. American Diabetes Association 71st Scientific Sessions. San Diego, CA. 2011.